Emerald-3 12+
ERT,INC
-
- Free
Screenshots
Description
This eCOA app is intended for use to collect patient reported data related to the Emerald-3 clinical trial
This eCOA App is intended for use collect patient reported outcomes (ePRO) relating to the Emerald-3 clinical trial. Patients must be given accounts by a participating site in order to log in to the app.
What’s New
Version 2.12.4 (38)
1. For QLQ-HCC18, IL165, IL163, IL164 and IL19 diaries text alignment is mismatch when compared to PDS. In device text alignment is displaying as Center aligned and text should be left aligned.
2. Update to the assessment schedule in the AutoLaunchDiary rule
App Privacy
The developer, ERT,INC, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Health & Fitness
Privacy practices may vary, for example, based on the features you use or your age. Learn More
Information
- Seller
- ERT, INC
- Size
- 81.5 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 12.0 or later.
- iPad
- Requires iPadOS 12.0 or later.
- iPod touch
- Requires iOS 12.0 or later.
- Languages
-
English
- Age Rating
- 12+ Infrequent/Mild Medical/Treatment Information
- Copyright
- © Clario, AstraZeneca
- Price
- Free